Rishi Modi is a Principal focused on U.S. Buyout, Growth, and Core opportunities in the healthcare sector. He is based in New York.
Mr. Modi currently serves as a member of the Board of Directors of Resonetics, Orsini Specialty Pharmacy, and TCW Group. Prior to joining Carlyle, Mr. Modi was a Vice President at L Catterton, where he focused on investment opportunities in the consumer health space. While at L Catterton, Mr. Modi was a Director of Dental Corporation of Canada and PatientPoint. Prior to that, Mr. Modi was with GI Partners in San Francisco and, before business school, worked in the healthcare groups at Warburg Pincus and Goldman, Sachs & Co.
Mr. Modi received his M.B.A. from the Graduate School of Business at Stanford University. He received a B.B.A. with high distinction from the Ross School of Business at the University of Michigan.